Analytical characterization of proteins at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

23 organizations at PepTalk 2027 present work in analytical characterization: 12 suppliers and service providers, 10 drug developers and 1 academic, government or non-profit body. Between them they bring 61 presentations to the program. Most represented: Genentech (10 on the program), Merck & Co. (8 on the program), Eli Lilly (5 on the program). As of Oct 17, 2026.

All 166 organizations at PepTalk 2027 →

Showing 1–7 of 23 organizations

Organization	PepTalk 2027 Attendance
Genentech South San Francisco, CA
gene.com Large pharma Roche Group biotechnology company discovering and developing antibody, peptide and other protein medicines.	Talk Mon Jan 18 10:00am–10:30am A Machine-Learning–Enabled Venom Peptide Platform for Rapid Drug Discovery SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Development of LRRC15-Binding Disulfide-Constrained Peptides for PET Imaging of Cancer-Associated Fibroblasts SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Talk Mon Jan 18 4:00pm–4:30pm Mirror-Image mRNA Display Uncovers Isoform-Selective D-Peptide Macrocycles Targeting a Cryptic KRAS Pocket SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Panel Mon Jan 18 4:30pm–5:00pm Breaking Down Silos—Integrating Disciplines to Accelerate Peptide Drug Discovery SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact · with EPOC Scientific, University of Florida, University of Queensland +1 more Talk Tue Jan 19 11:20am–11:50am De novo Design of Miniprotein Cytokine Mimics Targeting IL4Ra by Combining Diffusion Models, MD Simulations, and Phage Display Automation in Protein Discovery / Peptide Discovery & Engineering Predictive and AI-driven protein science Talk Tue Jan 19 2:30pm–3:00pm Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Automation in Protein Discovery Panel Tue Jan 19 5:45pm–6:05pm Women in AI Meet-Up Plenary · with Novo Nordisk Chair Wed Jan 20 8:15am–8:20am Chairperson's Remarks Peptide Discovery & Engineering Talk Wed Jan 20 9:35am–10:05am What Does the Future Hold for Antibody "Lab-in-the-Loop" Methods? Analytical Intelligence Talk Wed Jan 20 9:40am–10:05am Discovery and Characterization of Potent Macrocycle Inhibitors Peptide Discovery & Engineering Talk Wed Jan 20 3:00pm–3:30pm Overcoming in-Process Autolysis: A Robust Purification Strategy for Difficult-to-Purify Recombinant Peptidases Tools for Purification and Quality
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, called MSD outside the US and Canada, with biologics, vaccines and macrocyclic peptide research.	Talk Mon Jan 18 10:00am–10:30am When Execution is No Longer the Bottleneck: Reimagining Design of Experiments for Predictive, Data-Driven Protein Production SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 9:10am–9:40am Implementing Agentic AI and Autonomous Systems in Analytical Development Analytical Intelligence Talk Tue Jan 19 9:40am–10:10am Discovery of an NRAS Isoform and Activation-State-Selective Macrocyclic Peptide Automation in Protein Discovery / Peptide Discovery & Engineering Chair Wed Jan 20 8:30am–8:35am Chairperson's Remarks Analytical Intelligence Talk Wed Jan 20 11:10am–11:40am Modeling Stability to Support Biotherapeutics Development Analytical Intelligence Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Remarks Tools for Purification and Quality Talk Wed Jan 20 3:00pm–3:30pm Investigation of Low Molecular Weight (LMW) Formation of a Multispecific Antibody by Protease Inhibitor Study Biophysical Methods and Models Talk Wed Jan 20 3:30pm–4:00pm Rapid Benchtop ¹H-NMR for Real-Time Monitoring of Purification Performance and Product Quality Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Scaling Formulation Development with 384-Well ELISA for Stability, Potency, and Process Monitoring Tools for Purification and Quality Talk Thu Jan 21 2:55pm–3:20pm Enabling Oral and Parenteral GLP-1 Delivery through Biophysical and Molecular Characterizations Peptide Therapeutics: Emerging Modalities & Development
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company with peptide, antibody and other medicines in diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Jan 19 11:50am–12:20pm From Data Silos to Shared Insights: Democratizing Data and AI for Accelerated Biotherapeutics Analytics and Decision Making Analytical Intelligence Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Plenary · with Novo Nordisk, Prescient Design, Generate Biomedicines Predictive and AI-driven protein science Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Novo Nordisk +2 more Peptide discovery and developmentPredictive and AI-driven protein science Talk Wed Jan 20 5:40pm–6:10pm Predictive Accelerated Stability Studies: A Strategic Approach to Developing Oligonucleotide Therapeutics Biophysical Methods and Models
AbbVie North Chicago, IL
abbvie.com Large pharma Global drugmaker whose biologics work spans antibodies, antibody-drug conjugates and other protein therapeutics in immunology, oncology and neuroscience.	Talk Tue Jan 19 2:00pm–2:30pm Don't Fear the Noise: Partitioning Nuisance Variation from Biophysical Data to Raise the Ceiling for Predictive Models. Analytical Intelligence Talk Wed Jan 20 11:40am–12:10pm Fit-for-Purpose Automation for High-Throughput Antibody Production and Characterization Automation in Protein Discovery Talk Wed Jan 20 5:40pm–6:10pm Infrared Matrix-Assisted Laser Desorption Electrospray Ionization (IR-MALDESI): High-Throughput Mass Spectrometry at Scale Tools for Purification and Quality Panel Thu Jan 21 7:30am–8:10am Accelerated Stability Testing for Frozen and Lyophile Biologicals (proteins, LNPs, AAVs) Biophysical Methods and Models Talk Thu Jan 21 9:10am–9:40am Challenges in Protein Stability Prediction: Major Deviations from Arrhenius Behavior in Liquid, Frozen, and Lyophilized Formulations Biophysical Methods and Models
Johnson & Johnson Innovative Medicine
jnj.com Large pharma Pharmaceutical business of Johnson & Johnson, formerly Janssen, with antibody, bispecific and cell therapy medicines in oncology, immunology and neuroscience.	Talk Tue Jan 19 1:30pm–2:00pm Next-Generation NAM Platforms: Advancing Microphysiological Systems and AI-Enabled Assays for Human-Relevant Data Analytical Intelligence Talk Tue Jan 19 2:00pm–2:30pm Leveraging High-Throughput Stable Pool Data for Biologics Pipeline Advancement Automation in Protein Discovery Talk Tue Jan 19 2:30pm–3:00pm FAIR Data Capture and Application through Benchling Validated Cloud: A Structured Digital Future Analytical Intelligence Chair Wed Jan 20 8:30am–8:35am Chairperson's Remarks Automation in Protein Discovery Talk Wed Jan 20 11:10am–11:40am SATURN: An End-to-End Automated Platform for High-Throughput Sample Management and Preparation in Biologics Discovery Automation in Protein Discovery
Amgen Thousand Oaks, CA
amgen.com Large pharma Global biotechnology company that develops and manufactures biologic medicines, including antibodies and bispecific T cell engagers.	Talk Tue Jan 19 9:40am–10:10am Enabling Faster Clinical Development through Digital Analytics, Automation, and Integrated Process Understanding Analytical Intelligence Talk Wed Jan 20 3:30pm–4:00pm Characterization of Co-Formulated Therapeutic Proteins by Liquid Chromatography and Mass Spectrometry Biophysical Methods and Models Talk Thu Jan 21 11:20am–11:50am Beyond ProA: Strategies for Efficient Purification of Complex Protein Therapeutics from Screening to Scale-Up Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm MS in Industry: From Fundamental Gas-Phase Ion Structure to Therapeutic Project Support Biophysical Methods and Models
Regeneron Tarrytown, NY
regeneron.com Large pharma US biotechnology company with marketed antibody medicines, built on its VelocImmune humanized-mouse platform and in-house bispecific antibody engineering.	Talk Tue Jan 19 8:40am–9:10am AI-Powered Predictive Spectral Libraries for High-Confidence Sequence Variant Analysis in Therapeutic Antibodies Analytical Intelligence Talk Tue Jan 19 9:10am–9:40am Protein Expression and G Protein-Based Functional Characterization of Orphan GPCRs Recombinant Protein Production - Part 1 Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Talk Thu Jan 21 3:10pm–3:40pm A Streamlined Workflow Enabling Efficient Preclinical Development of Novel Protein Therapeutics through Risk Assessment and Enhanced Communication Bridging Research and CMC Biophysical Methods and Models